Microbot Medical appoints Rachel Vaknin as CFO, replacing David Ben Naim effective April 1, 2022

Microbot Medical Inc.

David Ben Naim resigned as CFO effective April 1, 2022; Rachel Vaknin appointed as successor.
Vaknin joined as VP Finance in Jan 2022; previously CFO at Imagry and FP&A manager at Mellanox.
Vaknin receives base salary NIS32,000/mo + NIS8,000 global comp, annual bonus up to 20% of salary, and options for 20,000 shares.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Rachel Vaknin

Chief Financial Officer

MBOT · Microbot Medical Inc.

Effective: 2022-04-01
Filed: April 6, 2022, 7:59 PM ET

As of April 1, 2022, the Company appointed Rachel Vaknin, age 43, as its Chief Financial Officer.

Departed

David Ben Naim

Chief Financial Officer

MBOT · Microbot Medical Inc.

Effective: 2022-04-01
Successor: Rachel Vaknin
Filed: April 6, 2022, 7:59 PM ET

As of April 1, 2022, David Ben Naim, the Chief Financial Officer of Microbot Medical Inc. (the “Company”), resigned from his position with the Company, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Rachel Vaknin was appointed as Chief Financial Officer at Microbot Medical Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

As of April 1, 2022, the Company appointed Rachel Vaknin, age 43, as its Chief Financial Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

David Ben Naim resigned as Chief Financial Officer at Microbot Medical Inc..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

As of April 1, 2022, David Ben Naim, the Chief Financial Officer of Microbot Medical Inc. (the “Company”), resigned from his position with the Company, effective immediately.

View on SEC.gov

Microbot Medical Inc. filing history →

Source: SEC EDGAR

accession 0001493152-22-009272

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.